AstraZeneca halts COVID19 vaccine trial after recipient unexplained illness Ruchika Sharma9 Sept 2020 1:05 PM ISTNew York: Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's...
COVID Vaccine: Bharat Biotech gets CDSCO nod to conduct Phase II Trials MD Bureau7 Sept 2020 11:30 AM ISTThese trials of BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for 4 days after they...
JnJ vaccine raises neutralizing antibodies, prevents severe COVID-19 in hamsters Ruchika Sharma6 Sept 2020 10:45 AM ISTThe vaccine, co-developed by the Beth Israel Deaconess Medical Center and Johnson & Johnson (JnJ), uses a common cold virus, called adenovirus...
CureVac anticipates to produce COVID-19 vaccine at scale by 2020 end Ruchika Sharma6 Sept 2020 10:00 AM ISTGermany: German biotech company Curevac expects to be able to produce the COVID-19 vaccine it is developing at scale by the end of the year,...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sept 2020 9:15 AM ISTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
Russian COVID vaccine Sputnik V induces antibody response in small human trials Medical Dialogues Bureau5 Sept 2020 11:36 AM ISTThese vaccines aim to stimulate both arms of the immune system -- antibody and T cell responses -- so they attack the virus when it is circulating in...
Sanofi, GSK begin human trial of coronavirus vaccine candidate MD Bureau4 Sept 2020 10:00 AM ISTParis: Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed Covid-19 vaccine...
Researchers step up efforts to develop effective Covid-19 vaccine in US MD Bureau2 Sept 2020 11:30 AM ISTWashington: Researchers across the US have stepped up efforts towards the development of an effective Covid-19 vaccine, as another vaccine...
Oxford COVID vaccine Phase 2 trial begins at Pune hospital MD Bureau27 Aug 2020 10:00 AM ISTNew Delhi : The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two...
India will get COVID-19 vaccine by 2020 end: Union Health Minister MD Bureau24 Aug 2020 12:45 PM ISTThe Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre- clinical...
Pfizer, BioNTech coronavirus vaccine shows fewer side effects MD Bureau22 Aug 2020 10:00 AM ISTNew York: US-based Pfizer and German biotech firm BioNTech announced positive results for the Phase 1 trial of their second Covid-19 vaccine...
COVID-19 Vaccine: Novavax initiates Phase IIb trial in South Africa Ruchika Sharma21 Aug 2020 9:00 AM ISTGaithersburg: Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious...
